• IDEAYA Biosciences held its annual shareholder meeting on June 16, 2026.
• Shareholders backed the appointment of PricewaterhouseCoopers as independent auditor for the year ending Dec. 31, 2026.
• Shareholders approved a board slate for Class I director seats, with terms running to the 2029 annual meeting.
• The board named Yujiro S. Hata as chair, with Terry Rosen as lead independent director, effective June 16, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-279427), on June 23, 2026, and is solely responsible for the information contained therein.